Actively Recruiting
Dose-Response Study of Aerobic Walking Exercise During Chemotherapy for Gastrointestinal Cancers to Reduce Side Effects
Led by Memorial Sloan Kettering Cancer Center · Updated on 2026-08-25
216
Participants Needed
8
Research Sites
6 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the effects of different levels of aerobic exercise on side effects experienced during treatment for gastrointestinal cancers. This includes studying how exercise may influence the bodys response to therapy, treatment dosing, and the need for additional medications to manage side effects. The study is a Phase 2 clinical trial focusing on supportive care during chemotherapy. Participants will be randomly assigned to one of three groups receiving varying doses of individualized treadmill walking exercise 90, 150, or 300 minutes per week. Exercise sessions will be delivered up to seven times weekly following a non-linear schedule that adjusts intensity and rest throughout chemotherapy treatment. Supervision and monitoring of exercise adherence will be conducted remotely using the TeleEx system. Facility access for treadmill use may be provided if participants lack home equipment. During the study, participants will be assessed for treatment delivery and adherence, including how many receive at least 90% of planned chemotherapy dose relative dose intensity. The study will also monitor treatment delays, dose reductions, and additional medication needs due to side effects. Participants exercise feasibility will be confirmed, including access to Wi-Fi and treadmill availability. The research team will collect data over five years to evaluate long-term outcomes and safety.
CONDITIONS
Brief Title
A Study on the Effects of Exercise on Side Effects From Treatment for Gastrointestinal Cancers
Research Team
J
Jessica Scott, PhD
A
Andrea Cercek, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here